1. Home
  2. AEI vs NSPR Comparison

AEI vs NSPR Comparison

Compare AEI & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alset Inc. (TX)

AEI

Alset Inc. (TX)

HOLD

Current Price

$2.69

Market Cap

91.4M

Sector

Real Estate

ML Signal

HOLD

Logo InspireMD Inc.

NSPR

InspireMD Inc.

HOLD

Current Price

$1.94

Market Cap

81.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AEI
NSPR
Founded
2014
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Building operators
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
91.4M
81.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AEI
NSPR
Price
$2.69
$1.94
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$4.50
AVG Volume (30 Days)
37.1K
101.5K
Earning Date
11-14-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$12,108,028.00
$7,779,000.00
Revenue This Year
N/A
$22.76
Revenue Next Year
N/A
$75.45
P/E Ratio
N/A
N/A
Revenue Growth
N/A
14.04
52 Week Low
$0.70
$1.59
52 Week High
$4.55
$3.80

Technical Indicators

Market Signals
Indicator
AEI
NSPR
Relative Strength Index (RSI) 47.78 47.60
Support Level $2.68 $1.74
Resistance Level $3.45 $2.00
Average True Range (ATR) 0.35 0.12
MACD 0.02 0.01
Stochastic Oscillator 26.74 48.72

Price Performance

Historical Comparison
AEI
NSPR

About AEI Alset Inc. (TX)

Alset Inc is a diversified holding company engaged through its subsidiaries in the development of EHome communities and other real estate, financial services, digital transformation technologies, biohealth activities, and consumer products with operations in the United States, Singapore, Hong Kong, Australia, and South Korea. The Company operates in four business segments: real estate, digital transformation technology, Biohealth, and other business activities, and it derives a majority of its revenue from the Real Estate segment.

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

Share on Social Networks: